Hemolysis: Clinical Trials

6 trials for Hemolysis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 16Completed 6

Follow Hemolysis: new trials by email Literature Review of Hemolysis trials Research Report on Hemolysis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Primaquine Enantiomers in G6PD Deficient Human Volunteers
RPQ, SPQ, Placebo - G6PD Deficiency
Phase 1CompletedUniversity of Mississippi, Oxford182020-09-012024-11-21
Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers Receiving a Seven Day Dose Regimen
RPQ, SPQ, Primaquine Phosphate - Malaria, Glucose 6 Phosphate Dehydrogenase Deficiency
Phase 1CompletedUniversity of Mississippi, Oxford362018-08-172019-05-14
Pilot Study to Assess Safety, Preliminary Efficacy and Pharmacokinetics of S.C. Pegcetacoplan (APL-2) in PNH Subjects.
Pegcetacoplan - Paroxysmal Nocturnal Hemoglobinuria
Phase 1CompletedApellis Pharmaceuticals, Inc.232015-12-012021-01-11
A Phase I Study to Assess the Safety of Pegcetacoplan (APL-2) as an Add-On to Standard of Care in Subjects With PNH
Pegcetacoplan - Paroxysmal Nocturnal Hemoglobinuria (PNH)
Phase 1CompletedApellis Pharmaceuticals, Inc.92015-02-232021-01-08
Topical Sodium Nitrite for Chronic Leg Ulcers in Adult Patients With Blood Disorders
Sodium Nitrite Cream - Sickle Cell Anemia, Sickle Cell Disease
Phase 1CompletedNational Heart, Lung, and Blood Institute (NHLBI)282011-03-152018-10-22
Probiotic Ingestion and Isoagglutinin Titers
Probiotic Supplement - Isoagglutinin-Mediated Hemolysis, Probiotic Toxicity
Phase 1CompletedNational Institutes of Health Clinical Center (CC)362009-04-282017-10-06

Narrower conditions

Anemia (3)  ·  Glucosephosphate Dehydrogenase Deficiency (2)  ·  Hematologic Diseases (2)  ·  Hemoglobinuria (2)  ·  Hemoglobinuria, Paroxysmal (2)  ·  Malaria (2)  ·  Anemia, Sickle Cell (1)  ·  Leg Ulcer (1)  ·  Thalassemia (1)

Broader conditions

Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Anemia, Hemolytic (5)  ·  Hemic and Lymphatic Diseases (5)  ·  Anemia, Hemolytic, Congenital (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Hematologic Diseases (3)  ·  Anemia (2)  ·  Bone Marrow Diseases (2)  ·  Carbohydrate Metabolism, Inborn Errors (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Infections (2)  ·  Male Urogenital Diseases (2)

Interventions

pegcetacoplan (2)  ·  Primaquine (1)

Sponsors

Apellis Pharmaceuticals, Inc. (2)  ·  University of Mississippi, Oxford (2)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  National Institutes of Health Clinical Center (CC) (1)

Countries

United States (5)  ·  Hong Kong (1)  ·  Malaysia (1)  ·  New Zealand (1)  ·  Thailand (1)

Top investigators

Federico Grossi, MD, PhD (2)  ·  Larry Walker, Ph.D. (1)  ·  Larry Walker, Phd (1)  ·  Matthew M Hsieh, M.D. (1)  ·  Susan F Leitman, M.D. (1)

Results publications

PMID 25938131, PMID 35869170, PMID 39079163